Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1986-7-28
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0048-5764
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
237-42
|
| pubmed:dateRevised |
2009-11-11
|
| pubmed:meshHeading |
pubmed-meshheading:3523579-Adult,
pubmed-meshheading:3523579-Anticonvulsants,
pubmed-meshheading:3523579-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:3523579-Dibenzocycloheptenes,
pubmed-meshheading:3523579-Dizocilpine Maleate,
pubmed-meshheading:3523579-Humans,
pubmed-meshheading:3523579-Psychiatric Status Rating Scales
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
The use of MK-801, a novel sympathomimetic, in adults with attention deficit disorder, residual type.
|
| pubmed:publicationType |
Journal Article
|